乳腺摄影术
乳腺癌
医学
置信区间
乳腺癌筛查
人工智能
背景(考古学)
乳腺癌意识
考试(生物学)
乳房成像
放射科
家庭医学
医学物理学
癌症
计算机科学
内科学
古生物学
生物
作者
Phuong Dung Trieu,Melissa L. Barron,Zhengqiang Jiang,Seyedamir Tavakoli Taba,Ziba Gandomkar,Sarah Lewis
摘要
Objectives This study explored the familiarity, perceptions and confidence of Australian radiology clinicians involved in reading screening mammograms, regarding artificial intelligence (AI) applications in breast cancer detection. Methods Sixty-five radiologists, breast physicians and radiology trainees participated in an online survey that consisted of 23 multiple choice questions asking about their experience and familiarity with AI products. Furthermore, the survey asked about their confidence in using AI outputs and their preference for AI modes applied in a breast screening context. Participants’ responses to questions were compared using Pearson’s χ2 test. Bonferroni-adjusted significance tests were used for pairwise comparisons. Results Fifty-five percent of respondents had experience with AI in their workplaces, with automatic density measurement powered by machine learning being the most familiar AI product (69.4%). The top AI outputs with the highest ranks of perceived confidence were ‘Displaying suspicious areas on mammograms with the percentage of cancer possibility’ (67.8%) and ‘Automatic mammogram classification (normal, benign, cancer, uncertain)’ (64.6%). Radiology and breast physicians preferred using AI as second-reader mode (75.4% saying ‘somewhat happy’ to ‘extremely happy’) over triage (47.7%), pre-screening and first-reader modes (both with 26.2%) (P < 0.001). Conclusion The majority of screen readers expressed increased confidence in utilising AI for highlighting suspicious areas on mammograms and for automatically classifying mammograms. They considered AI as an optimal second-reader mode being the most ideal use in a screening program. The findings provide valuable insights into the familiarities and expectations of radiologists and breast clinicians for the AI products that can enhance the effectiveness of the breast cancer screening programs, benefitting both healthcare professionals and patients alike.
科研通智能强力驱动
Strongly Powered by AbleSci AI